Pα+ Psychedelic Bulletin #155: MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists – Psychedelic Alpha

Featured content in this Issue:

  • MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists
  • Long-Term Effects of Microdosing Remain Key Unknown; Cardiac Concern
  • Psychedelics for SUDs: Policy, Not Just Pharmacology
  • and more…

This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.

Sign-in button

Join Button

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Subscribe

* indicates required